Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Keegan Barry-Holson"'
Autor:
Keegan Barry-Holson, David Steiner, Scott Wendroth, Athena Cherry, James L. Zehnder, Robert S. Ohgami
Publikováno v:
Human Pathology: Case Reports, Vol 10, Iss C, Pp 102-103 (2017)
Externí odkaz:
https://doaj.org/article/ee795de66e7c470baa81c8d30bd77368
Autor:
Yoon-A Kang, Aurélie Hérault, Eric M. Pietras, Mikhail Binnewies, Stephanie Leong, Scott A. Armstrong, Berthold Göttgens, Fernando J Calero-Nieto, Si Yi Zhang, S. Haihua Chu, Keegan Barry-Holson, Xiaonan Wang, Emmanuelle Passegué
Publikováno v:
Nature, vol 544, iss 7648
Although many aspects of blood production are well understood, the spatial organization of myeloid differentiation in the bone marrow remains unknown. Here we use imaging to track granulocyte/macrophage progenitor (GMP) behaviour in mice during emerg
Autor:
James L. Zehnder, Athena M. Cherry, David F. Steiner, Robert S. Ohgami, Keegan Barry-Holson, Scott Wendroth
Publikováno v:
Human Pathology: Case Reports, Vol 10, Iss C, Pp 102-103 (2017)
Autor:
Sitharthan Kamalakaran, Russell K. Brynes, Keegan Barry-Holson, Imran Siddiqi, Lizalynn M. Dias, Kevin R. Kelly, Charles Ma, Irene Kang, Venkata Thodima, Jane Houldsworth, Julia Friedman, Raghavendra Padmanabhan
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 29(6)
A predominantly diffuse growth pattern and CD23 co-expression are uncommon findings in nodal follicular lymphoma and can create diagnostic challenges. A single case series in 2009 (Katzenberger et al) proposed a unique morphologic variant of nodal fo
Autor:
Eric M. Pietras, Jerald P. Radich, Keegan Barry-Holson, Marion Jeanne, Olga Sala-Torra, Damien Reynaud, Emmanuelle Passegué, Mikhail Binnewies, Alain Mir
Publikováno v:
Cancer Cell. 20(5):661-673
SummaryUsing a mouse model recapitulating the main features of human chronic myelogenous leukemia (CML), we uncover the hierarchy of leukemic stem and progenitor cells contributing to disease pathogenesis. We refine the characterization of CML leukem
Autor:
Emmanuelle Passegué, Haihua Chu, Scott A. Armstrong, Aurélie Hérault, Keegan Barry-Holson, Eric M. Pietras, Mikhail Binnewies, Berthold Göttgens, Fernando Calero, Stephanie Leong, Si Yi Zhang
Publikováno v:
Experimental Hematology. 44:S79-S80
Autor:
John R. Ohlfest, Keegan Barry-Holson, Trevor E. Angell, Alan L. Epstein, Peisheng Hu, Melissa G. Lechner, Katherine A. Murphy, Connor H. Church, Saman S. Karimi
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 36(9)
Immune profiling has been widely used to probe mechanisms of immune escape in cancer and identify novel targets for therapy. Two emerging uses of immune signatures are to identify likely responders to immunotherapy regimens among individuals with can
Autor:
Deepa Subramanyam, Cassandra D. Belair, Haijiang Lin, Keegan Barry-Holson, Robert Blelloch, Scott C. Kogan, Emmanuelle Passegué
The PML-RARα oncogene is the central effector of acute promyelocytic leukemia (APL). PML-RARα physically interacts with epigenetic-modifying enzymes including DNA methyltransferases (Dnmt) to suppress critical downstream targets. Here, we show that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29089049ae8e31b86a5345b30fa16195
https://europepmc.org/articles/PMC3021794/
https://europepmc.org/articles/PMC3021794/
Autor:
Michelle M. Le Beau, Emer Bourke, Emmanuelle Passegué, Keegan Barry-Holson, Matthew R. Warr, David L. Alexander, Mary Mohrin, Ciaran G. Morrison
Most adult stem cells, including hematopoietic stem cells (HSCs), are maintained in a quiescent or resting state in vivo. Quiescence is widely considered to be an essential protective mechanism for stem cells that minimizes endogenous stress caused b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e800ead68d636660a16c54fe8c6f63
http://hdl.handle.net/10379/12931
http://hdl.handle.net/10379/12931
Autor:
Sarah M. Russell, Keegan Barry-Holson, Corey Kelsom, Jingzhong Pang, Peisheng Hu, Alan L. Epstein, Melissa G. Lechner
Publikováno v:
Cancer Research. 72:1553-1553
Cancer immunotherapy uses a patient's own immune system to recognize and eliminate malignant cells. The potential advantages of this approach over conventional treatments include the systemic trafficking of immune cells to treat primary and metastati